WebJul 1, 2024 · June 30, 2024 11:58 PM Eastern Daylight Time. HYDERABAD, India-- ( BUSINESS WIRE )--Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its ... WebSep 8, 2024 · RDY / Dr. Reddy's Laboratories Ltd. (Current Report of Foreign Issuer) SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 January 2024 Commission File …
Bristol Myers Squibb - Bristol Myers Squibb Announces Settlement …
WebJun 11, 2024 · Risks that could affect our future operating results are described in our United States Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2024. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking ... WebJul 1, 2024 · June 30, 2024 11:58 PM Eastern Daylight Time. HYDERABAD, India-- ( BUSINESS WIRE )--Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, … marketwatch eli lilly
Dr. Reddy’s Laboratories Limited announces filing of Annual …
WebSep 17, 2024 · Dr. Reddy’s licensed to sell volume-limited amounts of generic lenalidomide in the U.S. beginning on a confidential date after the March 2024 date previously granted to Natco Dr. Reddy’s also licensed to sell generic lenalidomide in the U.S. without volume limitation beginning on January 31, 2026 The earliest licensed entry of any generic … WebDr. Reddy’s announces ANDA filing for Olanzapine ODT. Hyderabad, India, March 11 2003: Dr. Reddy’s Laboratories (NYSE: RDY) today announced that the Company had filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration for Olanzapine Orally Disintegrating Tablets (ODT), equivalent to 5mg, 10mg, 15mg and … WebDr. Reddy's Laboratories Ltd. ADR SEC filings breakout by MarketWatch. View the RDY U.S. Securities and Exchange Commission reporting information. marketwatch epr